LeMaitre Vascular, Inc.
LMAT
$78.82
-$2.50-3.07%
| Weiss Ratings | LMAT - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Good | |||
| Risk Index | Fair | |||
| Risk Grade | C | |||
| Reward Grade | B | |||
| Rating Factors | LMAT - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | Weak | |||
| Growth Index | Excellent | |||
| Efficiency Index | Excellent | |||
| Solvency Index | Excellent | |||
| Total Return Index | Fair | |||
| Volatility Index | Fair | |||
| Beta / Standard Deviation | LMAT - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 1.22 | |||
| Price History | LMAT - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | -9.18% | |||
| 30-Day Total Return | -21.10% | |||
| 60-Day Total Return | -21.52% | |||
| 90-Day Total Return | -10.69% | |||
| Year to Date Total Return | -13.61% | |||
| 1-Year Total Return | 17.42% | |||
| 2-Year Total Return | 60.52% | |||
| 3-Year Total Return | 93.21% | |||
| 5-Year Total Return | 274.07% | |||
| 52-Week High % Change | -28.07% | |||
| 52-Week Low % Change | 26.33% | |||
| Price | LMAT - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $109.58 | |||
| 52-Week Low Price | $62.39 | |||
| 52-Week Low Price (Date) | Apr 19, 2024 | |||
| 52-Week High Price (Date) | Nov 25, 2024 | |||
| Valuation | LMAT - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 1.78B | |||
| Enterprise Value | 1.66B | |||
| Price/Earnings (TTM) | 40.82 | |||
| Earnings Per Share (TTM) | 1.93 | |||
| Earnings Per Share Growth | 45.20% | |||
| Price/Earnings To Growth | 0.90 | |||
| Price/Sales (TTM) | 8.21 | |||
| Price/Book (Q) | 5.27 | |||
| Enterprise Value/Revenue (TTM) | 7.57 | |||
| Price | $78.82 | |||
| Enterprise Value/EBITDA (TTM) | 26.87 | |||
| Enterprise Value/EBIT | 31.84 | |||
| Market Cap Category | Small Cap | |||
| Dividends and Shares | LMAT - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 22.90M | |||
| Dividend Yield | 0.86% | |||
| Div. Per Share (Most Recent) | $0.20 | |||
| Dividend Per Share (TTM) | $0.68 | |||
| Payout Ratio (TTM) | 32.65% | |||
| Dividend Per Share (Most Recent) | $0.20 | |||
| Company Info | LMAT - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 781 221 2266 | |||
| Address | 63 Second Avenue Burlington, MA 01803 | |||
| Website | www.lemaitre.com | |||
| Country | United States | |||
| Year Founded | 1983 | |||
| Profitability | LMAT - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | 23.76% | |||
| Profit Margin | 20.02% | |||
| Management Effectiveness | LMAT - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | 7.27% | |||
| Return on Equity | 13.87% | |||
| Income Statement | LMAT - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 219.86M | |||
| Total Revenue (TTM) | 219.86M | |||
| Revenue Per Share | $9.60 | |||
| Gross Profit (TTM) | 150.90M | |||
| EBITDA (TTM) | 61.93M | |||
| EBIT (TTM) | 52.26M | |||
| Net Income (TTM) | 44.04M | |||
| Net Income Avl. to Common (TTM) | 44.04M | |||
| Total Revenue Growth (Q YOY) | 13.98% | |||
| Earnings Growth (Q YOY) | 32.12% | |||
| EPS Diluted (TTM) | 1.93 | |||
| EPS Diluted Growth (Q YOY) | 30.04% | |||
| Balance Sheet | LMAT - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 299.72M | |||
| Cash Per Share (Q) | $13.09 | |||
| Total Current Assets (Q) | 402.19M | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | 337.29M | |||
| Current Ratio (Q) | 13.141 | |||
| Book Value Per Share (Q) | $14.96 | |||
| Total Assets (Q) | 551.82M | |||
| Total Current Liabilities (Q) | 30.61M | |||
| Total Debt (Q) | 185.69M | |||
| Total Liabilities (Q) | 214.53M | |||
| Total Common Equity (Q) | 337.29M | |||
| Cash Flow | LMAT - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -200.12M | |||
| Cash from Financing (TTM) | 158.10M | |||
| Net Change in Cash (TTM) | 1.34M | |||
| Levered Free Cash Flow (TTM) | 29.38M | |||
| Cash from Operations (TTM) | 44.12M | |||
